Detalhe da pesquisa
1.
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo.
Biochem J;
479(3): 401-424, 2022 02 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35147166
2.
Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice.
Clin Sci (Lond);
136(22): 1661-1681, 2022 11 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36331065
3.
The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension.
Clin Sci (Lond);
135(14): 1631-1647, 2021 07 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34296750
4.
Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies.
Circulation;
121(10): 1235-43, 2010 Mar 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20194880
5.
Images in cardiovascular medicine. Subacute massive pulmonary embolism diagnosed by transesophageal echocardiography.
Circulation;
116(12): e352-3, 2007 Sep 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17875976
6.
Pacemaker-mediated dermatitis.
Europace;
10(11): 1354, 2008 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18757864
7.
Definition of failed lysis may have influenced outcome in the MERLIN trial.
J Am Coll Cardiol;
45(5): 808; author reply 808-9, 2005 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15734633
8.
Presentation of an embolised Amplatzer septal occluder to the main pulmonary artery 2 years after implantation.
Int J Cardiol;
131(3): e106-7, 2009 Jan 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17949836
9.
Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance.
Catheter Cardiovasc Interv;
56(1): 105-6; author reply 106, 2002 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11979542